🟠 Amgen and Celltrion settle litigation over denosumab biosimilar CT-P41, delaying U.S. entry until June 1, 2025.
#glp1 #obesity #weightloss $LLY #Zepbound #biopharma #ozempic $NVO $vktx $zeal $tern $alt @FDA
#glp1 #obesity #weightloss #LLY #Zepbound #biopharma #ozempic #NVO #vktx #zeal #tern #alt